CompletedNCT03814291
A Dose Escalation Study of IBI302 in Patients With Wet Age-related Macular Degeneration
PHASE1 · 31 planned enrolment
- Countries listed
- 1
- Registry update
- April 17, 2025
immortal.lifeTrial registrations containing the exact intervention label IBI302.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE1 · 31 planned enrolment
PHASE3 · 600 planned enrolment